SCHEMBL19022013

SCHEMBL19022013

CCNC(=O)Cc1cn(C)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
MTOR P42345 1/20 0.43
HRH4 Q9H3N8 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
S1PR1 P21453 1/20 0.39
NTRK1 P04629 1/20 0.37
HPGDS O60760 1/20 0.37
NAMPT P43490 1/20 0.35
CPB2 Q96IY4 3/20 0.34
CPB1 P15086 1/20 0.34
GPR142 Q7Z601 1/20 0.33
MAPK1 P28482 1/20 0.33
ACACB O00763 1/20 0.33
EGLN2 Q96KS0 1/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288521 0.87 LMNA (0.47) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL12019273 0.84 CYP2C9 (0.41) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL19009013 0.83 CYP2C9 (0.46) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL10272325 0.83 CYP2C9 (0.40) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL14230528 0.81 CYP2C9 (0.39) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL12017874 0.80 NTRK1 (0.38) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL19000039 0.79 S1PR1 (0.45) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL14665172 0.77 CYP2C9 (0.47) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL12174842 0.77 CYP2C9 (0.50) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL27340963 0.77 CYP2C9 (0.50) CYP2C9TSHRCYP2C19MTORHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106607-A1 POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS MERCK PATENT GMBH (DE) 2017-06-22 WO disclosed